portfolio-201-600x450

Funding and Investment

Require funding or expansion capital? Seeking attractive investment opportunities in this sector?

More >

portfolio-201-600x450

Commercialization

Aquapreneur is the place to meet potential partners, collaborators and experts who can assist you to succeed.

More >

portfolio-201-600x450

Licensing

Have a patented technology or IP you want to monetize? Looking for complimentary technology or in-licensing?

More >

Categories

Categories

  • Norway salmon farm may be purchased by Mitsubishi for $1.4 bn

    By Aquapreneur on September 22, 2014

    Norway’s Cermaq have recommended shareholders accept a $1.4 billion cash bid unveiled by Mitsubishi that would create the world’s second largest salmon farming companyNorway’s Cermaq have recommended shareholders accept a $1.4 billion cash bid unveiled by Mitsubishi that would create the world’s second largest salmon farming company. More info

  • FAO review highlights food and feed uses for fish and shellfish by-products

    By Aquapreneur on September 18, 2014

    By-products may constitute as much as 70% of fish and shellfish after industrial processing and much focus has been on converting these into commercial products. The aim of this paper is therefore to evaluate important challenges and to consider the most realistic options in the use of by-products. Certain by-products like heads, frames and off-cuts from filleting of fish may

  • Seaweed an effective alternative for iodine supplementation, study finds

    By Aquapreneur on September 12, 2014

    A study in the British Journal of Nutrition shows that seaweed supplementation can be an effective alternative for boosting the levels of iodine in women deficient in this vital nutrient. More info

  • A Sea Change in IBD Treatment?

    By Aquapreneur on September 12, 2014

    A Florida immunologist and macrophage biologist recently received a substantial grant from the National Institutes of Health to investigate a possible role for chitin, an abundant component of shrimp, crab and lobster shells, in treating inflammatory bowel disease. Yoshimi Shibata, PhD, professor of biomedical science at the Charles E. Schmidt College of Medicine of Florida Atlantic University, in Boca Raton,

  • Icelandic Collaboration for GlycoMar Limited with Lumpfish Byproducts

    By Aquapreneur on September 12, 2014

    Scottish biotechnology company GlycoMar, Icelandic marine biotechnology company Biopol and the University of University of Akureyri are pleased to announce their research collaboration. The consortium, led by Biopol, has received grant support from the AVS R&D Fund of Ministry of Fisheries in Iceland to evaluate the commercial viability of production of high value nutraceutical products from lumpfish. In this project,

Host

Sponsers

Partners